Contrast Medium-Induced Acute Kidney Injury: Comparison of Intravenous and Intraarterial Administration of Iodinated Contrast Medium

被引:63
作者
Karlsberg, Ronald P. [1 ]
Dohad, Suhail Y. [1 ]
Sheng, Rubin [2 ]
机构
[1] Cedars Sinai Heart Inst, Cardiovasc Res Inst So Calif, Los Angeles, CA USA
[2] GE Healthcare Med Diagnost, Clin Res & Dev, Princeton, NJ USA
关键词
DOUBLE-BLIND; INDUCED NEPHROPATHY; CORONARY-ANGIOGRAPHY; RENAL-INSUFFICIENCY; COMPUTED-TOMOGRAPHY; CT ANGIOGRAPHY; DISEASE; IODIXANOL; TRIAL;
D O I
10.1016/j.jvir.2011.03.020
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To compare the incidence of contrast medium-induced acute kidney injury (AKI) after intravenous (IV) administration of iodixanol for computed tomographic (CT) angiography versus intraarterial (IA) injection of iodixanol or low osmolar contrast medium (LOCM) for digital subtraction angiography (DSA) within the same population suspected of peripheral arterial occlusive disease (PAOD). Materials and Methods: CT angiography was performed with IV iodixanol 320 mgI/mL. After a washout period of 3-14 days, DSA was performed with IA iodixanol or LOCM. Serum creatinine was measured at baseline and 24 hours after administration. Contrast medium-induced AKI was defined by a serum creatinine increase of at least 25% versus baseline at 24 hours. Data were analyzed with chi(2) statistics. Results: Mean baseline serum creatinine values were comparable between CT angiography with IV contrast medium and DSA with IA contrast medium (93.3 mu mol/L +/- 52.92 vs 92.8 mu mol/L +/- 61.70). The incidence of AKI for CT angiography after IV iodixanol administration was 7.6% (20 of 264), which was not statistically different than the 8.7% incidence (22 of 253) for DSA with IA iodixanol or LOCM (P = .641). In the 143 patients who received only iodixanol for both procedures, incidences of contrast medium-induced AKI were comparable after IV (7.0%) and IA (5.6%) administration (P = .626). Conclusions: The rates of contrast medium-induced AKI are not statistically different between IV iodixanol for CT angiography and IA iodixanol or another LOCM for DSA in the same population with suspected PAOD.
引用
收藏
页码:1159 / 1165
页数:7
相关论文
共 23 条
[11]   Contrast-induced nephrotoxicity: Clinical landscape [J].
Katzberg, RW ;
Haller, C .
KIDNEY INTERNATIONAL, 2006, 69 :S3-S7
[12]   Systematic review of computed tomographic angiography for assessment of carotid artery disease [J].
Koelemay, MJW ;
Nederkoorn, PJ ;
Reitsma, JB ;
Majoie, CB .
STROKE, 2004, 35 (10) :2306-2312
[13]   The PREDICT study: A randomized double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure [J].
Kuhn, Matthew J. ;
Chen, Nan ;
Sahani, Dushyant V. ;
Reimer, Dan ;
van Beek, Edwin J. R. ;
Heiken, Jay P. ;
So, George J. .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2008, 191 (01) :151-157
[14]   Contrast nephropathy following computed tomography angiography of the chest for pulmonary embolism in the emergency department [J].
Mitchell, A. M. ;
Kline, J. A. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (01) :50-54
[15]   Frequency of serum creatinine changes in the absence of iodinated contrast material: Implications for studies of contrast nephrotoxicity [J].
Newhouse, Jeffrey H. ;
Kho, David ;
Rao, Qasim A. ;
Starren, Justin .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2008, 191 (02) :376-382
[16]   Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: Effect on kidney function [J].
Nguyen, Shaun A. ;
Suranyi, Pal ;
Ravenel, James G. ;
Randall, Patrick K. ;
Romano, Peter B. ;
Strom, Kimberly A. ;
Costello, Philip ;
Schoepf, U. Joseph .
RADIOLOGY, 2008, 248 (01) :97-105
[17]   A Prospective, Double-blind, Randomized, Controlled Trial on the Efficacy and Cardiorenal Safety of lodixanol vs. lopromide in Patients With Chronic Kidney Disease Undergoing Coronary Angiography With or Without Percutaneous Coronary Intervention [J].
Nie, Bin ;
Cheng, Wan-Jun ;
Li, Yan-Fang ;
Cao, Zheng ;
Yang, Qing ;
Zhao, Ying-Xin ;
Guo, Yong-He ;
Zhou, Yu-Jie .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2008, 72 (07) :958-965
[18]  
Polena S, 2005, P W PHARMACOL SOC, V48, P134
[19]   Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial [J].
Rudnick, Michael R. ;
Davidson, Charles ;
Laskey, Warren ;
Stafford, J. Lawrence ;
Sherwin, Paul F. .
AMERICAN HEART JOURNAL, 2008, 156 (04) :776-782
[20]   Cardiac angiography in renally impaired patients (CARE) study - A randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease [J].
Solomon, Richard J. ;
Natarajan, Madhu K. ;
Doucet, Serge ;
Sharma, Samin K. ;
Staniloae, Cezar S. ;
Katholi, Richard E. ;
Labinaz, Marino ;
Moreyra, Abel E. .
CIRCULATION, 2007, 115 (25) :3189-3196